Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection

[1]  George A. Williams,et al.  The Pandemic Is Not Associated with Endophthalmitis Decrease after Anti–Vascular Endothelial Growth Factor Injections , 2022, Ophthalmology.

[2]  Jonathan E. Schmitz,et al.  Potential impact of oral flora dispersal on patients wearing face masks when undergoing ophthalmologic procedures , 2021, BMJ Open Ophthalmology.

[3]  S. Au,et al.  Delayed hospital presentation of acute central retinal artery occlusion during the COVID-19 crisis: the HORA study brief report No. 4 , 2021, Indian journal of ophthalmology.

[4]  F. Ziemssen,et al.  The Role and Views of Ophthalmologists During the COVID-19 Pandemic , 2021, Clinical ophthalmology.

[5]  S. Lebeer,et al.  Cotton and Surgical Face Masks in Community Settings: Bacterial Contamination and Face Mask Hygiene , 2021, Frontiers in Medicine.

[6]  M. Moe,et al.  Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis , 2021, Acta ophthalmologica.

[7]  F. Ziemssen,et al.  International survey on COVID‐19 pandemic: personal protective measures during fundus examination , 2021, Acta ophthalmologica.

[8]  Ajay E. Kuriyan,et al.  The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti–Vascular Endothelial Growth Factor Injections , 2021, Ophthalmology.

[9]  E. Mahé,et al.  The face mask-touching behavior during the COVID-19 pandemic: Observational study of public transportation users in the greater Paris region: The French-mask-touch study , 2021, Journal of Transport and Health.

[10]  I. García-Basterra,et al.  FACE MASK CONTAMINATION DURING COVID-19 PANDEMIA. A STUDY ON PATIENTS RECEIVING INTRAVITREAL INJECTIONS , 2021, Retina.

[11]  Sophia Y Ghauri,et al.  ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS DURING THE COVID-19 PANDEMIC WITH IMPLEMENTATION OF UNIVERSAL MASKING , 2021, Retina.

[12]  I. Krolo,et al.  Mask-Associated Dry Eye During COVID-19 Pandemic–How Face Masks Contribute to Dry Eye Disease Symptoms , 2021, Medical archives.

[13]  Chao Liu,et al.  The impact and effectiveness of the general public wearing masks to reduce the spread of pandemics in the UK: a multidisciplinary comparison of single-use masks versus reusable face masks , 2020, UCL open environment.

[14]  Ajay E. Kuriyan,et al.  Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections , 2020, American Journal of Ophthalmology.

[15]  A. Gaggar,et al.  The closed eye harbours a unique microbiome in dry eye disease , 2020, Scientific Reports.

[16]  R. Ehrlich,et al.  Patients Wearing Facemasks During Intravitreal Injections May Be at Higher Risk of Endophthalmitis. , 2020, Retina.

[17]  M. Landray,et al.  COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England , 2020, The Lancet.

[18]  M. Galdiero,et al.  Current Evidence on the Ocular Surface Microbiota and Related Diseases , 2020, Microorganisms.

[19]  A. Poostchi,et al.  Delayed presentation and increased prevalence of proliferative vitreoretinopathy for primary rhegmatogenous retinal detachments presenting during the COVID-19 pandemic lockdown , 2020, Eye.

[20]  B. Cowling,et al.  Respiratory virus shedding in exhaled breath and efficacy of face masks , 2020, Nature Medicine.

[21]  U. Schmidt-Erfurth,et al.  2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations , 2018, Ophthalmologica.

[22]  J. Vander,et al.  MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY , 2016, Retina.

[23]  C. Creuzot-Garcher,et al.  Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome. , 2015, American journal of ophthalmology.

[24]  K. Fujita,et al.  Minimizing the endophthalmitis rate following intravitreal injections using 0.25 % povidone–iodine irrigation and surgical mask , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[25]  B. Foot,et al.  Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes , 2012, Eye.

[26]  Gary C. Brown,et al.  Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. , 2011, Ophthalmology.

[27]  Theodore Leng,et al.  REDUCING ORAL FLORA CONTAMINATION OF INTRAVITREAL INJECTIONS WITH FACE MASK OR SILENCE , 2011, Retina.

[28]  Benjamin J. Cowling,et al.  Influenza Virus Aerosols in Human Exhaled Breath: Particle Size, Culturability, and Effect of Surgical Masks , 2010, Occupational and Environmental Medicine.

[29]  P. Szurman,et al.  [Recommendation for the implementation of intravitreal injections--statement of the German Retina Society, the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA)]. , 2005, Klinische Monatsblatter fur Augenheilkunde.

[30]  George A. Williams,et al.  Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength. , 2019, Ophthalmology. Retina.